查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1565661

週期性發燒綜合症市場，按產品類型、治療方法、分佈、年齡層、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Periodic Fever Syndrome Market, By Product Type, By Treatment, By Distribution, By Age Group, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023 年週期性發燒症候群市場規模為 6.209 億美元，2024 年至 2032 年複合年成長率為 4.80%。

週期性發燒綜合症市場-市場動態

遺傳性疾病的日益普及導致對週期性發燒症候群的需求

遺傳性疾病的日益流行正在推動對週期性發燒綜合症 (PFS) 等疾病的有效治療的需求不斷增加。隨著越來越多的人被診斷出患有與自體發炎性疾病相關的基因突變，例如家族性地中海熱、高免疫球蛋白D 症候群和TNF 受體相關週期性症候群(TRAPS)，對專門醫療干預措施的需求不斷增加。週期性發燒綜合症的特徵是反覆發燒和全身炎症，如果不及時治療，可能會嚴重影響患者的生活品質。遺傳性疾病病例的增加提高了醫療保健專業人員和研究人員的認知，推動先進的診斷工具和療法來應對 PFS 帶來的獨特挑戰。根據世界衛生組織統計，全球每年估計有 24 萬名新生兒在出生後 28 天內死於先天性疾病。先天性疾病導致另外 17 萬名 1 個月至 5 歲的兒童死亡。因此，製藥和生物技術部門正在努力開發創新療法來管理和減輕與這些疾病相關的症狀，旨在改善患者的治療結果並減輕整體疾病負擔。

週期性發燒綜合症市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 4.80% 左右的複合年成長率成長

根據產品類型細分，預計遺傳性週期性發燒症候群將在 2023 年呈現最大市場佔有率

根據治療細分，藥物是 2023 年的主導類型

從分佈細分來看，醫院藥局是2023年的主導類型

按地區分類，北美是 2023 年的主要收入來源

週期性發燒綜合症市場-細分分析：

全球週期性發燒綜合症市場根據產品類型、治療、分佈、年齡層和地區進行細分。

根據產品類型，市場分為兩類：遺傳性週期性發燒綜合症和後天性週期性發燒綜合症。醫療保健專業人員和患者意識的提高導致了診斷率的提高。有了更好的診斷工具（包括基因檢測），更多的人被識別出患有 HPFS。先進治療方案的開發，特別是白細胞介素 (IL)-1 抑制劑（例如阿那白滯素和卡那奴單抗）等生物製劑，改善了治療結果。這些創新療法提供更有效的症狀管理，進而提高採用率。

根據治療方法，市場分為四類：藥物、基因治療、症狀治療和其他新興療法。基因療法提供了解決 PFS 潛在遺傳原因的標靶治療的潛力。由於許多 PFS 病症是由特定基因突變引起的，因此基因療法可以直接糾正這些突變或調節相關基因的表達。總體而言，標靶治療潛力、技術進步以及支持性研究和監管環境的結合有助於基因治療在週期性發燒綜合症市場中佔據較高的市場佔有率。

週期性發燒綜合症市場 - 地理洞察

由於人們對罕見遺傳疾病的認知不斷提高、診斷工具的進步和治療方案的改進，北美週期性發燒綜合症市場正在經歷顯著成長。美國憑藉完善的醫療基礎設施、大型製藥公司的存在以及受益於先進療法的患者人數不斷成長而在市場上佔據主導地位。加拿大也發揮關鍵作用，不斷擴大研究計畫並增加對罕見疾病治療的投資。美國食品藥物管理局 (FDA) 和加拿大衛生部的監管支持促進了新療法的批准，進一步加速了該地區的市場成長。

週期性發燒綜合症市場-競爭格局：

週期性發燒綜合症（PFS）市場的特徵是存在專注於罕見疾病和孤兒藥的主要製藥公司。主要參與者包括諾華 (Novartis)、瑞典孤兒 Biovitrum (Sobi) 和再生元製藥 (Regeneron Pharmaceuticals)。諾華透過其生物療法 Ilaris（canakinumab），透過治療各種 PFS 亞型（包括隱熱蛋白相關週期性症候群 (CAPS)），佔據了重要的市場佔有率。 Sobi 非常重視免疫學和罕見疾病治療，其產品 Kineret（阿那白滯素）在解決 PFS 方面也發揮著至關重要的作用。 Regeneron 以其在發炎性疾病方面的作用而聞名，提供了 Dupixent (dupilumab)，可用於探索 PFS。專注於利基治療的小型生物製藥公司進一步推動了市場，並不斷研究和開發新療法。競爭是由創新、療效和獲得孤兒藥指定的機會所推動的，從而在這個罕見疾病市場中創造了一個充滿活力的環境。

最新進展：

2020 年 6 月，美國國立衛生研究院下屬的國家人類基因組研究所 (NHGRI) 的研究人員發現了僅影響兒童的反覆非傳染性發燒和瘡的可能原因的線索。有些基因與這種稱為 PFAPA 症候群的症候群有關，可能會帶來新的治療方法。

2020 年 9 月，諾華宣布美國食品藥物管理局 (FDA) 同時批准三項批准擴大 Ilaris (canakinumab) 的用途，用於治療三種罕見且不同類型的周期性發燒症候群。

目錄

第1章：週期性發燒症候群市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 依產品類型分類的周期性發燒綜合症市場片段
    • 週期性發燒綜合症治療市場片段
    • 週期性發燒綜合症市場片段（依分佈）
    • 依年齡層分類的周期性發燒綜合症市場片段
    • 按國家/地區分類的周期性發燒綜合症市場片段
    • 按地區分類的周期性發燒綜合症市場片段
  • 競爭洞察

第 3 章：週期性發燒症候群主要市場趨勢

  • 週期性發燒綜合症市場促進因素
    • 市場促進因素的影響分析
  • 週期性發燒症候群市場限制
    • 市場限制影響分析
  • 週期性發燒症候群市場機會
  • 週期性發燒症候群市場未來趨勢

第 4 章：週期性發燒症候群產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：週期性發燒綜合症市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：週期性發燒綜合症市場格局

  • 週期性發燒綜合症市場佔有率分析，2023 年
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：週期性發燒綜合症市場 - 依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 遺傳性週期性發燒綜合症
      • 家族性地中海熱 (FMF)
      • 高免疫球蛋白血症 D 症候群 (HIDS)
      • 腫瘤壞死因子受體相關週期性症候群 (TRAPS)
    • 後天性週期性發燒綜合症
      • 週期性發燒、口瘡性口炎、咽炎、腺炎 (PFAPA)
      • 其他非遺傳性週期性發燒綜合症

第 8 章：週期性發燒症候群市場 - 依治療分類

  • 概述
    • 按處理方式分類的細分市場佔有率分析
    • 藥物
    • 基因治療
    • 症狀治療
    • 其他新興療法

第 9 章：週期性發燒症候群市場 - 按分佈

  • 概述
    • 按分佈分類的細分市場佔有率分析
    • 醫院藥房
    • 零售藥局
    • 網路藥局
    • 專科診所

第 10 章：週期性發燒綜合症市場 - 按年齡層

  • 概述
    • 按處理方式分類的細分市場佔有率分析
    • 兒科患者
    • 成人患者

第 11 章：週期性發燒症候群市場 - 依地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 週期性發燒綜合症北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模與預測（以不同處理方式）
    • 北美市場規模和預測（按分佈）
    • 北美市場規模和預測（按年齡層）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲週期性發燒綜合症主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模與預測（按處理方式）
    • 歐洲市場規模和預測（按分佈）
    • 歐洲市場規模和預測（按年齡層）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 週期性發燒綜合症亞太地區主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（以不同處理方式）
    • 亞太地區市場規模與預測（按分佈）
    • 亞太地區市場規模與預測（依年齡層）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲週期性發熱症候群主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（以不同處理方式）
    • 拉丁美洲市場規模與預測（按分佈）
    • 拉丁美洲市場規模與預測（按年齡層）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲週期性發燒症候群主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東及非洲市場規模及預測（依不同處理方式）
    • 中東和非洲市場規模及預測（按分佈）
    • 中東和非洲市場規模及預測（按年齡層）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 週期性發燒綜合症行業

  • 競爭儀表板
  • 公司簡介
    • Novartis AG
    • Swedish Orphan Biovitrum AB (Sobi)
    • Regeneron Pharmaceuticals, Inc.
    • Pfizer Inc.
    • Horizon Therapeutics plc
    • Takeda Pharmaceutical Company Ltd.
    • AbbVie Inc.
    • Eli Lilly and Company
    • Amgen Inc.
    • Sanofi SA
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3857

REPORT HIGHLIGHT

Periodic Fever Syndrome Market size was valued at USD 620.90 million in 2023, expanding at a CAGR of 4.80% from 2024 to 2032.

The Periodic Fever Syndrome market focuses on treatments for a group of rare autoinflammatory disorders characterized by recurrent episodes of fever and inflammation, including Familial Mediterranean Fever (FMF), TNF receptor-associated periodic syndrome (TRAPS), and Hyper-IgD syndrome (HIDS). The market is driven by advances in genetic research, which help in early diagnosis and personalized treatment options. Key therapeutic approaches include biologics, such as interleukin-1 inhibitors and TNF inhibitors, offering relief from symptoms and reducing flare-ups. Increased awareness among healthcare professionals and rising patient support initiatives also support market growth. Major players include Novartis, Sobi, and Pfizer, contributing to drug development and clinical trials aimed at addressing these disorders more effectively.

Periodic Fever Syndrome Market- Market Dynamics

Growing Prevalence of Genetic Disorders Leading the Need for Periodic Fever Syndrome

The growing prevalence of genetic disorders is driving an increased demand for effective treatments for conditions like Periodic Fever Syndrome (PFS). As more individuals are diagnosed with genetic mutations linked to autoinflammatory diseases, such as familial Mediterranean fever, hyperimmunoglobulin D syndrome, and TNF receptor-associated periodic syndrome (TRAPS), the need for specialized medical interventions has escalated. Periodic Fever Syndrome, characterized by recurrent fevers and systemic inflammation, can significantly impact patients' quality of life if left untreated. This rise in genetic disorder cases has heightened awareness among healthcare professionals and researchers, pushing for advanced diagnostic tools and therapies to address the unique challenges posed by PFS. According to the World Health Organization, an estimated 240,000 newborns die worldwide within 28 days of birth every year due to congenital disorders. Congenital disorders cause a further 170,000 deaths of children between the ages of 1 month and 5 years. Consequently, the pharmaceutical and biotechnology sectors are working towards developing innovative treatments to manage and alleviate the symptoms associated with these conditions, aiming to improve patient outcomes and reduce the overall disease burden.

Periodic Fever Syndrome Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.80% over the forecast period (2024-2032)

Based on product type segmentation, Hereditary Periodic Fever Syndromes was predicted to show maximum market share in the year 2023

Based on treatment segmentation, Medications was the leading type in 2023

Based on distribution segmentation, Hospital Pharmacies was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Periodic Fever Syndrome Market- Segmentation Analysis:

The Global Periodic Fever Syndrome Market is segmented on the basis of Product Type, Treatment, Distribution, Age Group, and Region.

The market is divided into two categories based on product type: Hereditary Periodic Fever Syndromes, and Acquired Periodic Fever Syndromes. Increased awareness among healthcare professionals and patients has led to higher diagnosis rates. With better diagnostic tools, including genetic testing, more individuals are being identified with HPFS. The development of advanced therapeutic options, particularly biologics like interleukin (IL)-1 inhibitors (e.g., anakinra and canakinumab), has improved treatment outcomes. These innovative treatments offer more effective symptom management, leading to higher adoption.

The market is divided into four categories based on treatment: Medications, Gene Therapy, Symptomatic Treatment, and Other Emerging Therapies. Gene therapy offers the potential for targeted treatments that address the underlying genetic causes of PFS. Since many PFS conditions are caused by specific genetic mutations, gene therapy can directly correct these mutations or modulate the expression of the genes involved. Overall, the combination of targeted treatment potential, technological advancements and supportive research and regulatory environments contribute to the high market share of gene therapy in the Periodic Fever Syndrome market.

Periodic Fever Syndrome Market- Geographical Insights

The Periodic Fever Syndrome market in North America is experiencing notable growth, driven by an increasing awareness of rare genetic conditions, advancements in diagnostic tools, and improved treatment options. The United States dominates the market due to a well-established healthcare infrastructure, the presence of major pharmaceutical companies, and a growing patient population benefiting from advanced therapies. Canada also plays a key role, with expanding research initiatives and rising investment in rare disease treatments. Regulatory support from the U.S. Food and Drug Administration (FDA) and Health Canada has facilitated the approval of new treatments, further accelerating market growth in the region.

Periodic Fever Syndrome Market- Competitive Landscape:

The Periodic Fever Syndrome (PFS) market is characterized by the presence of key pharmaceutical companies focusing on rare diseases and orphan drugs. Major players include Novartis, Swedish Orphan Biovitrum (Sobi), and Regeneron Pharmaceuticals. Novartis, through its biologic therapy Ilaris (canakinumab), holds a significant market share by treating a variety of PFS subtypes, including Cryopyrin-Associated Periodic Syndromes (CAPS). Sobi, with its strong emphasis on immunology and rare disease therapies, also plays a crucial role in addressing PFS with its product Kineret (anakinra). Regeneron, known for its work in inflammatory diseases, offers Dupixent (dupilumab), which can be explored for PFS. The market is further bolstered by smaller biopharmaceutical companies focusing on niche treatments, with ongoing research and development for novel therapies. Competition is driven by innovation, efficacy, and access to orphan drug designations, creating a dynamic environment in this rare disease market.

Recent Developments:

In June 2020, Researchers at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, discovered clues to the possible cause of recurring, non-contagious fevers and sores that affect only children. Several genes have been implicated with the syndrome, known as PFAPA syndrome which could lead to new treatments.

In September 2020, Novartis announced that the US Food and Drug Administration (FDA) has granted three simultaneous approvals for the expanded use of Ilaris (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERIODIC FEVER SYNDROME MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Novartis AG
  • Swedish Orphan Biovitrum AB (Sobi)
  • Regeneron Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Horizon Therapeutics plc
  • Takeda Pharmaceutical Company Ltd.
  • AbbVie Inc.
  • Eli Lilly and Company
  • Amgen Inc.
  • Sanofi S.A.
  • Others

GLOBAL PERIODIC FEVER SYNDROME MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Hereditary Periodic Fever Syndromes
  • Familial Mediterranean Fever (FMF)
  • Hyperimmunoglobulinemia D Syndrome (HIDS)
  • Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS)
  • Acquired Periodic Fever Syndromes
  • Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA)
  • Other Non-Hereditary Periodic Fever Syndromes

GLOBAL PERIODIC FEVER SYNDROME MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

  • Medications
  • Gene Therapy
  • Symptomatic Treatment
  • Other Emerging Therapies

GLOBAL PERIODIC FEVER SYNDROME MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Specialty Clinics

GLOBAL PERIODIC FEVER SYNDROME MARKET, BY AGE GROUP - MARKET ANALYSIS, 2019 - 2032

  • Pediatric Patients
  • Adult Patients

GLOBAL PERIODIC FEVER SYNDROME MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Periodic Fever Syndrome Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Periodic Fever Syndrome Market Snippet by Product Type
    • 2.1.2. Periodic Fever Syndrome Market Snippet by Treatment
    • 2.1.3. Periodic Fever Syndrome Market Snippet by Distribution
    • 2.1.4. Periodic Fever Syndrome Market Snippet by Age Group
    • 2.1.5. Periodic Fever Syndrome Market Snippet by Country
    • 2.1.6. Periodic Fever Syndrome Market Snippet by Region
  • 2.2. Competitive Insights

3. Periodic Fever Syndrome Key Market Trends

  • 3.1. Periodic Fever Syndrome Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Periodic Fever Syndrome Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Periodic Fever Syndrome Market Opportunities
  • 3.4. Periodic Fever Syndrome Market Future Trends

4. Periodic Fever Syndrome Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Periodic Fever Syndrome Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Periodic Fever Syndrome Market Landscape

  • 6.1. Periodic Fever Syndrome Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Periodic Fever Syndrome Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Hereditary Periodic Fever Syndromes
      • 7.1.2.1. Familial Mediterranean Fever (FMF)
      • 7.1.2.2. Hyperimmunoglobulinemia D Syndrome (HIDS)
      • 7.1.2.3. Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS)
    • 7.1.3. Acquired Periodic Fever Syndromes
      • 7.1.3.1. Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA)
      • 7.1.3.2. Other Non-Hereditary Periodic Fever Syndromes

8. Periodic Fever Syndrome Market - By Treatment

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
    • 8.1.2. Medications
    • 8.1.3. Gene Therapy
    • 8.1.4. Symptomatic Treatment
    • 8.1.5. Other Emerging Therapies

9. Periodic Fever Syndrome Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
    • 9.1.2. Hospital Pharmacies
    • 9.1.3. Retail Pharmacies
    • 9.1.4. Online Pharmacies
    • 9.1.5. Specialty Clinics

10. Periodic Fever Syndrome Market - By Age Group

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
    • 10.1.2. Pediatric Patients
    • 10.1.3. Adult Patients

11. Periodic Fever Syndrome Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Periodic Fever Syndrome Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Periodic Fever Syndrome Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Periodic Fever Syndrome Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Periodic Fever Syndrome Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Periodic Fever Syndrome Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Periodic Fever Syndrome Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Novartis AG
    • 12.2.2. Swedish Orphan Biovitrum AB (Sobi)
    • 12.2.3. Regeneron Pharmaceuticals, Inc.
    • 12.2.4. Pfizer Inc.
    • 12.2.5. Horizon Therapeutics plc
    • 12.2.6. Takeda Pharmaceutical Company Ltd.
    • 12.2.7. AbbVie Inc.
    • 12.2.8. Eli Lilly and Company
    • 12.2.9. Amgen Inc.
    • 12.2.10. Sanofi S.A.
    • 12.2.11. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us